novo retatrutide ADA: CSO says 'jury still out' on CagriSema v. Novo Nordisk CEO Dustar: Obesity
Description
Size sunduumuz bu gven ortamnda, karar verirken ekstra rahatlk hissedebilirsiniz
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardio-vascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
Prescribing outside the licensed indications and doses constitutes off-label use, which requires prescribers to document their rationale, obtain informed consent, and provide appropriate monitoring
Parker VE, Robertson D, Wang T, Hornigold DC, Petrone M, Cooper AT, et al
A diet rich in fatty foods can lead to fat accumulation in the intestines, contributing to weight gain
